This HTML5 document contains 173 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33379271
rdf:type
wikibase:Item
schema:description
2008年論文 artikulong pang-agham wissenschaftlicher Artikel tudományos cikk videnskabelig artikel (udgivet 2008) vitenskapelig artikkel vědecký článek naučni članak επιστημονικό άρθρο vedecký článok articol științific 2008年論文 мақолаи илмӣ tieteellinen artikkeli scienca artikolo vetenskaplig artikel 2008年论文 artículo científico publicado en 2008 2008年論文 article científic artigo científico научна статия bài báo khoa học 2008年论文 مقالة علمية artigo científico (publicado na 2008) article scientific 2008 թվականի հունիսին հրատարակված գիտական հոդված 2008年の論文 artikull shkencor מאמר מדעי სამეცნიერო სტატია artículu científicu espublizáu en 2008 2008년 논문 наукова стаття, опублікована в червні 2008 2008年论文 ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون 2008 nî lūn-bûn مقالهٔ علمی 2008年论文 2008年論文 wetenschappelijk artikel mokslinis straipsnis мақолаи илмӣ научни чланак articolo scientifico artykuł naukowy 2008年论文 teaduslik artikkel научни чланак 2008年論文 article scientifique (publié 2008) vitskapeleg artikkel bilimsel makale scientific article научная статья บทความทางวิทยาศาสตร์ 2008年论文 artigo científico (publicado na 2008) 2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
p:P577
wds:Q33379271-D740305B-7655-4132-B101-95D7B7564122
wdt:P577
2008-06-01T00:00:00Z
p:P407
wds:Q33379271-2C7E1E18-EF87-4BD8-A1EE-B3138A66DB57
wdt:P407
wd:Q1860
p:P2860
wds:Q33379271-C4D80916-794F-4910-BAE8-501DBA2C3E4D wds:Q33379271-DD3B2EF1-9F6D-49F1-88DF-9EEEB0A9664D wds:Q33379271-ED6747C3-55E1-4B20-B46B-1EEABB7E76B2 wds:Q33379271-8B98F1A7-474B-439F-B377-73E6B4EBA3CD wds:Q33379271-9D5F447A-144D-455F-9FA7-1CB2B3BF0500 wds:Q33379271-A5437681-1CBE-47EC-883B-E708CC2F3B1B wds:Q33379271-AA87EB70-C4F8-4306-9AE2-E492F9F19C98 wds:Q33379271-AE04283C-F530-4D4C-8022-FF5878D7E6A8 wds:Q33379271-B2E44845-1333-47DA-8701-00A48B8A01B1 wds:Q33379271-B47E31F1-7DEA-404B-BCD5-A1E4D21CBCD0 wds:Q33379271-B52093D8-4BD9-4FC7-9AB7-C6D9284AA08B wds:Q33379271-B60532F9-F368-48D0-BE56-FC2073E9CA99 wds:Q33379271-B6FA0A4A-80F3-4199-A87B-1751F9226787 wds:Q33379271-21429AAD-B134-4D82-A689-32212F7C5B43 wds:Q33379271-2A4D6D0A-BB17-4C26-9CF5-3A67F8FA3C01 wds:Q33379271-3BA6D001-3A15-41F4-9C33-FEC29E12FC25 wds:Q33379271-6206FF6C-F9A5-43DD-8C7F-DBA274EF094C wds:Q33379271-665F391E-1582-4059-BE2A-3E1C8935513C wds:Q33379271-724550BB-811A-4912-B10E-CC270CEE63CB wds:Q33379271-73DC8A27-EB8B-44CB-92D7-50B2C9A71E20 wds:Q33379271-80353FDF-A4BA-41BB-8F9D-276522ACD26C wds:Q33379271-08E64B31-0AD6-4CE4-A639-4D4AF1DE27CB wds:Q33379271-11A2A2E8-CE24-49DC-92C2-2980EF9A1690 wds:Q33379271-2011C9A1-3A88-4C74-B5EB-7A47ACF62C08
wdt:P2860
wd:Q33358104 wd:Q34566598 wd:Q41231593 wd:Q70365924 wd:Q83215418 wd:Q71102740 wd:Q45231163 wd:Q44865180 wd:Q36211421 wd:Q34560933 wd:Q79750587 wd:Q27860904 wd:Q33337764 wd:Q40361923 wd:Q36622264 wd:Q29616236 wd:Q77321925 wd:Q45231150 wd:Q33374394 wd:Q46904870 wd:Q40446595 wd:Q44951979 wd:Q29617572 wd:Q73535629
p:P2093
wds:Q33379271-065D47FB-FB7E-4062-AEEC-953BEF575372 wds:Q33379271-4663D2AC-295B-45EB-9C5D-CB5B88F02969 wds:Q33379271-60AC38FC-4230-46C8-ADA6-10C5C9DC46AA wds:Q33379271-A4794D76-4042-40DB-AE2A-E0831C746968 wds:Q33379271-89E0AD96-9DDD-4299-85CD-B7BA82FBCE53 wds:Q33379271-860AC05A-B528-41B8-B4C3-A03D684381D6 wds:Q33379271-D023D386-8B9A-44D1-B0C9-392F3D03B102 wds:Q33379271-EBF29D78-CE8E-40F2-B085-D337AAA0A259 wds:Q33379271-ED166BAD-AB3E-48DE-9493-25F2FACB39D7
wdt:P2093
Amani Asnacios Olivier Romano Samy Louafi S Olivier Rosmorduc Touraj Mansoubakht Laetitia Fartoux Mohamed Hebbar Pascal Artru Chloe Tesmoingt
rdfs:label
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study
skos:prefLabel
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study
schema:name
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study
p:P50
wds:Q33379271-A1576925-0BEF-4E3C-B973-204BC32472D4 wds:Q33379271-33EF7FC5-C5BA-49DE-8C5D-4BF28D1D2DD3
wdt:P50
wd:Q41784351 wd:Q43252014
p:P1476
wds:Q33379271-CFD52539-E558-44BB-B6F1-B3545E47CFB8
wdt:P1476
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study
p:P304
wds:Q33379271-6B70EA20-B1A7-479F-A24D-7040F082FC49
wdt:P304
2733-2739
p:P31
wds:Q33379271-55109B07-135E-40ED-B07D-386A3047ADF1
wdt:P31
wd:Q13442814
p:P921
wds:Q33379271-F5D6C6E8-676E-4BFC-9508-98EB25F0B179 wds:Q33379271-E923F7A2-64AA-43E1-8646-59A5334D1D2A wds:Q33379271-C1A5C13B-01EE-4D60-8425-965E7B2128ED wds:Q33379271-C425937C-207A-4126-8C53-F1672CC46985
wdt:P921
wd:Q422327 wd:Q1148337 wd:Q420296 wd:Q6934595
p:P698
wds:Q33379271-3E57DF1F-9D12-4AD7-8C4A-F754BDC964D3
wdtn:P698
n10:18412149
wdt:P698
18412149
p:P1433
wds:Q33379271-33137655-0BD5-431B-834E-DCF3A281D0C2
wdt:P1433
wd:Q326041
p:P433
wds:Q33379271-C8153EB1-9A22-44FE-8CD5-D750BD9C3A07
p:P478
wds:Q33379271-87000D16-E3F9-46E2-B5BD-38F87D4A1D9F
wdt:P433
12
wdt:P478
112
p:P356
wds:Q33379271-B454C0CD-A682-44F4-AF00-D82780703B59
wdtn:P356
n12:CNCR.23489
wdt:P356
10.1002/CNCR.23489
p:P5875
wds:Q33379271-DC954B99-97E5-4A22-A35D-BCD0990ABFCA
wdt:P5875
5440841